Upregulation of miR-29b in lesional skin and serum samples from AD patients is associated with enhanced keratinocyte apoptosis through inhibiting Bcl-2-like protein 2 (Bcl2L2), contributing to epithelial barrier dysfunction impaired in AD [120]. This evidence concerns the gene BCL2L2 and Alzheimer disease.